Preclinical studies have demonstrated that SPs can be successfully applied in radionuclide molecular imaging for detecting tumor metastases, as well as for controlling the efficacy and dynamics of chemotherapy for HER2-expressing cancers. The gene discussed is ERBB2; the disease is neoplasm.